Extensive Intraductal Component in Breast Cancer: What Role in Disease-Free Survival?

[1]  T. Kawahara,et al.  Using Propensity Scores for Causal Inference: Pitfalls and Tips , 2021, Journal of epidemiology.

[2]  Y. Xiong,et al.  Tumor size and focality in breast carcinoma: Analysis of concordance between radiological imaging modalities and pathological examination at a cancer center. , 2020, Annals of diagnostic pathology.

[3]  T. Ohta,et al.  Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast , 2020, medRxiv.

[4]  Seigo Nakamura,et al.  Liquid biopsy for the detection of clinical biomarkers in early breast cancer: new insights and challenges. , 2020, Pharmacogenomics.

[5]  H. Gómez,et al.  Multigene assays in early breast cancer: Insights from recent phase 3 studies. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  M. Truffi,et al.  Radio‐guided and clip‐guided preoperative localization for malignant microcalcifications offer similar performances in breast‐conserving surgery , 2019, The breast journal.

[7]  Abhijit A. Patel,et al.  Overall survival is improved when DCIS accompanies invasive breast cancer , 2019, Scientific Reports.

[8]  S. Mazzucchelli,et al.  Radio‐guided vs clip‐guided localization of nonpalpable mass‐like lesions of the breast from a screened population: A propensity score‐matched study , 2019, Journal of surgical oncology.

[9]  H. Kim,et al.  Mammography, US, and MRI to Assess Outcomes of Invasive Breast Cancer with Extensive Intraductal Component: A Matched Cohort Study. , 2019, Radiology.

[10]  J. Seco Calvo,et al.  Influence of ductal carcinoma in situ on the outcome of invasive breast cancer. A prospective cohort study. , 2019, International journal of surgery.

[11]  J. Landercasper,et al.  Update of the American Society of Breast Surgeons Toolbox to address the lumpectomy reoperation epidemic. , 2018, Gland surgery.

[12]  San-Gang Wu,et al.  Prognostic value of ductal carcinoma in situ component in invasive ductal carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis , 2018, Cancer management and research.

[13]  A. Sieuwerts,et al.  TUMORIGENESIS AND NEOPLASTIC PROGRESSION Gene Expression Differences between Ductal Carcinoma in Situ with and without Progression to Invasive Breast Cancer , 2022 .

[14]  M. Bonzini,et al.  Cavity Shaving Reduces Involved Margins and Reinterventions Without Increasing Costs in Breast-Conserving Surgery: A Propensity Score-Matched Study , 2017, Annals of Surgical Oncology.

[15]  M. Bonzini,et al.  Localization of nonpalpable breast lesions with sonographically visible clip: optimizing tailored resection and clear margins. , 2015, American journal of surgery.

[16]  Tae-Min Kim,et al.  Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer , 2015, Oncotarget.

[17]  I. Zapardiel,et al.  Influence of the in situ component in 389 infiltrating ductal breast carcinomas , 2013, Breast Cancer.

[18]  A. Gavin,et al.  Increased diagnosis and detection rates of carcinoma in situ of the breast , 2012, Breast Cancer Research and Treatment.

[19]  J. Reis-Filho,et al.  Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra‐tumour genetic heterogeneity and clonal selection , 2012, The Journal of pathology.

[20]  T. Yau,et al.  Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer , 2010, British Journal of Cancer.

[21]  K. McMasters,et al.  Does ductal carcinoma in situ accompanying invasive carcinoma affect prognosis? , 2009, Surgery.

[22]  J. Coebergh,et al.  Screening caused rising incidence rates of ductal carcinoma in situ of the breast , 2009, Breast Cancer Research and Treatment.

[23]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[24]  Kornelia Polyak,et al.  Ductal Carcinoma in Situ of the Breast , 2004, Strahlentherapie und Onkologie.

[25]  H. Kooy,et al.  Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  J. Jacquemier,et al.  An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy. , 1990, British Journal of Cancer.

[27]  S. Schnitt,et al.  Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy , 1984, Cancer.

[28]  Virginia Espina,et al.  What is the malignant nature of human ductal carcinoma in situ? , 2011, Nature Reviews Cancer.